PanoramicaGraficoNotizieSchermataTrader

BNP Paribas Knock-Out GRF/  DE000PC6AJW0  /

Frankfurt Zert./BNP
19/11/2024  18:20:57 Var.-0.380 Denaro18:27:55 Lettera- Sottostante Prezzo di esercizio Expiration date Tipo di opzione
4.790EUR -7.35% 4.780
Quantità in denaro: 628		 -
Quantità in lettera: -		 GRIFOLS 5.8064 EUR 31/12/2078 Call
GlobeNewswire 31/07 GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HB...
GlobeNewswire 29/07 Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strength...
TeleTrader 08/07 Grifols family, Brookfield consider €5.5B takeover bid for Grifols
GlobeNewswire 01/07 Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Newsfile Corp 27/06 GRFS SHAREHOLDER ALERT: Johnson Fistel Announces Class Action Investigation of Grifols, S.A. for Pot...
GlobeNewswire 18/06 Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
GlobeNewswire 17/06 Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
GlobeNewswire 20/05 GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Adva...
GlobeNewswire 18/04 Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire 04/04 Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire 31/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 29/03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire 25/03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire 23/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 22/03 Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investig...
GlobeNewswire 20/03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire 15/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 01/03 GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols S.A. (NASDAQ: GRFS) ...
GlobeNewswire 14/02 Grifols announces positive topline phase 3 fibrinogen clinical trial results
GlobeNewswire 12/02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman
GlobeNewswire 11/02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 08/02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman
GlobeNewswire 02/02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 02/02 Grifols S.A.: Company Investigated by the Portnoy Law Firm
GlobeNewswire 01/02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman